Calidi Biotherapeutics (CLDI) Other Accumulated Expenses (2024)
Calidi Biotherapeutics (CLDI) recorded quarterly Other Accumulated Expenses of $638000.0 in Q4 2024, up 2.9% quarter-over-quarter from $620000.0 in Q3 2024.
Calidi Biotherapeutics (CLDI) Other Accumulated Expenses (2024) Analysis & Trends
Calidi Biotherapeutics' Other Accumulated Expenses history runs 1 years deep, the most recent figure standing at $638000.0 for Q4 2024.
- In Q4 2024, Other Accumulated Expenses changed N/A year-over-year to $638000.0; the TTM figure through Dec 2024 stood at $638000.0 (changed N/A YoY), while the FY2024 annual figure was $638000.0, changed N/A from the prior year.
- Other Accumulated Expenses was $638000.0 for Q4 2024 at Calidi Biotherapeutics, up from $620000.0 in the prior quarter.
- In the past five years, Other Accumulated Expenses ranged from a high of $638000.0 in Q4 2024 to a low of $567000.0 in Q1 2024.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Alterity Therapeutics | 788,338.31 Bn | 788,338.28 Bn | - |
| 2 | Belite Bio | 56,560.00 Bn | 56,560.00 Bn | - |
| 3 | Quantum Biopharma | 17,329.30 Bn | 17,329.30 Bn | - |
| 4 | Legend Biotech | 3,341.00 Bn | 3,340.71 Bn | 242.10 Mn |
| 5 | Akari Therapeutics | 1,727.91 Bn | 1,727.91 Bn | - |
| 6 | Evaxion A | 1,536.68 Bn | 1,536.67 Bn | - |
| 7 | Psyence Biomedical | 238.34 Bn | 238.33 Bn | - |
| 8 | Vertex Pharmaceuticals | 113.42 Bn | 106.17 Bn | 2.59 Bn |
| 9 | Abivax | 95.45 Bn | 95.45 Bn | - |
| 10 | Calidi Biotherapeutics | - | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2024 | 638,000.00 |
| Sep 30, 2024 | 620,000.00 |
| Jun 30, 2024 | 597,000.00 |
| Mar 31, 2024 | 567,000.00 |